Concurrent use of ketamine and monoamine oxidase inhibitors in the treatment of depression: A letter to the editor

Gen Hosp Psychiatry. 2018 Sep-Oct:54:62-64. doi: 10.1016/j.genhosppsych.2018.05.007. Epub 2018 May 22.
No abstract available

Keywords: Depression; Ketamine; Monoamine oxidase inhibitor; Safety; Treatment-refractory.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / adverse effects
  • Antidepressive Agents / pharmacology*
  • Depressive Disorder, Major / drug therapy*
  • Drug Therapy, Combination / adverse effects
  • Female
  • Humans
  • Ketamine / administration & dosage
  • Ketamine / adverse effects
  • Ketamine / pharmacology*
  • Middle Aged
  • Monoamine Oxidase Inhibitors / adverse effects
  • Monoamine Oxidase Inhibitors / pharmacology*

Substances

  • Antidepressive Agents
  • Monoamine Oxidase Inhibitors
  • Ketamine